Careers      Contact Us
  Message from the Chairman of the Board

Director Profiles


Please click on any board member below to read more.


Danadams Pharmaceuticals recognizes the strategic role of the Board of Directors in sustaining the viability of the company in the long-term. The company therefore has an eight-member Board of Directors comprising highly qualified and experienced professionals drawn from the arena of business and academia. Six of the Board members are non-executive.

The Board of Directors is at the forefront of leading and controlling the company, setting the strategic direction, and monitoring the activities of Executive Management. To set the tone and standards for a culture of high performance in the company, the Board has adopted a board charter that outlines an evolving set of corporate governance guidelines.

The Board meets at least four times a year to deliberate on germane issues including corporate strategy and its implementation, regular review of performance, approval of Annual Report and Accounts, and succession planning.Three key committees have also been put in place to enable the Board to handle specialized matters in detail using the appropriate expertise: Finance and Audit, Administration and Remuneration, and a Technical Committee.

There is every indication that with the good corporate governance climate that has been generated, the Management of Danadams will continue to enhance shareholder value while taking into account the interests of its major stakeholders.

Emmanuel Mahama Baba
Chairman of the Board





Emmanuel Mahama Baba: Former CEO of Vanguard Life Assurance Company and President of the Ghana Insurers Association until his recent retirement in 2009, Emmanuel Mahama Baba knows what is required strategically to sustain business success. In his role as Chairman of the Board and of the Executive Committee, Baba focuses on bringing his expertise as a Chartered Accountant and Chartered Insurer, and his wide professional experience across several industries to bear on the decisions and actions governing Danadams. He believes the benefit of his position includes helping the CEO to avoid blind spots, and to balance the risks inherent in company growth against maintaining strong financials.

Baba also advocates that Danadams needs to grow independent of personalities that have shaped it, and therefore sees one of the cardinal roles of the current Board of Directors as ensuring the existence of the comprehensive policies, systems and structures that the company needs to ensure that Management and Staff can run autonomous of the CEO's presence. He is of the conviction that with the right people, policies, systems and structures in place, Danadams will continue to grow in leaps and bounds.

Baba holds a B.Com degree from the University of Cape Coast, Ghana and an MBA from the Manchester Business School, University of Manchester. He is a Member of the Board of Governors, All Nations University, Koforidua, and Member of the National Insurance Commission, and of the Executive Council of the Insurance Institute of Ghana. Baba also holds directorships in several other organisations including Vanguard Life Assurance, Vanguard Properties Development Company limited, City Investments Limited, World Vision (Ghana), and Ghana Leasing Company Limited. In April 2011, Baba ended a two-year tenure as the Chairman of the Graphic Communications Group Limited. He currently consults mainly for the Vanguard Group, and also conducts training in the area of corporate governance and strategic planning.



Professor Kwame Frimpong is a graduate of the University of Ghana and Yale Law School in the United States. He is a Professor of Law and a qualified barrister in Ghana. In an academic career of over three decades, he has taught at the University of Botswana as well as the University of Ghana. He has also served as a United Nations Legal Adviser. He returned to Ghana in 2007, and is currently the founding Dean of the new law school set up by the Ghana Institute of Management and Public Administration (GIMPA)




Mr. Awal holds a Master Degree of Arts and Journalism and an MBA in Marketing.He was formerly the Managing Director of Graphic Communications Group Ghana Limited. He launched his own publication in August 2011, The Finder newspaper. He was named the Marketing Man of the Year 2009 by Chartered Institute of Marketing (CIMG).


Ike Onyechi is a B.Pharm (Hons) graduate of the University of Nigeria, Nsukka. He has an an MBA from ESUT Business School as well as an Advanced Management Programme Certificate from Lagos Business School. Mr. Onyechi is a fellow of the Pharmaceutical Society of Nigeria (PSN) and is also a fellow (as well as Chairman, Nigeria Chapter) of West Africa Post Graduate College of Pharmacists (WAPCP). He is a Member, Board of Directors, Neimeth International Pharmaceuticals Plc.
He is also a Member of the International Pharmaceutical Federation (F.I.P) and American Pharmaceutical Association (APHA).


Mr. Edward Dua Agyeman has a distinguished career in education and training, and he has also served as Auditor-General of Ghana. He obtained a BA (Hons) in Business Studies from Middlesex University (UK) and a Masters in Public Administration from the Ghana Institute of Management and Public Administration (GIMPA), Ghana. He also holds a Certificate of Education from Garnet College, University of London. He is a Fellow Member of the Association of Chartered Certified Accountants, UK (FCCA) and a Member of the Institute of Chartered Accountants (Ghana).


Dennis Vormawor has a B.SC. in Administration from Pacific Western University. He was formerly Deputy Secretary General of Ghana’s Trades Union Congress from 1992-1999 and later served as CEO of Labor Enterprises Trust Company. Prior to that he was Deputy Chief Accountant of Ghana Education Service. He is a member of the International Industrial Relations Council and a certified mediator for the National Labour Commission.


Cognisant of the fact that Danadams Pharmaceuticals operates in a specialized industry, the Board has sought to include relevant technical guidance and proficiency with the appointment of Prof Mahama Duwiejua. Not only is Duwiejua a pharmacist by profession (he is a product of the Kwame Nkrumah University of Science and Technology), he is also highly respected as an educator and influential lobbyist for local pharmaceutical manufacturing. His presence on the Board allows Danadams to widen its regional network in Africa, where Duwiejua is well-connected with pharmaceutical leaders through the nature of his work over the years. In addition to his primary contribution as Head of the Board's Technical Committee, Duwieja would like the company to benefit from his continuing advocacy in government sectors and the sub-region. Formerly the Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Duwiejua is presently serving as Executive Secretary for the National Council for Tertiary Education, where he is focused on moving tertiary education to higher levels. He is also the author of several pharmaceutical publications.

Dr Deo Barakamfitiye  

The newest addition to the Board is Dr Deo Barakamfitiye, who will be starting his tenure in 2012. Barakamfitiye is not only a medical Doctor who has extensive and high level experience in management of human and financial resources. He has also served in key roles in the World Health organization. His diplomatic skills and experience in the health industry at a global level will be valued additions to the Board. Barakamfitiye has been elaborating health priority issues such as Polio eradication and Initiative for Malaria control in Africa for the 21st Century, and advocating at the top continental political level (OAU). He has successfully mobilized the International Community for funding of those priorities through the WHO. Early warning, prevention, control and mitigation of epidemics were among his responsibilities at Africa level. Today Barakamfitiye heads up the youngest Institute for Strategic Studies (ISS) office in Dakar, Senegal, as the Office Director. The ISS is a pan-African applied policy research institute that seeks to add critical balance and objectivity by providing timely, empirical research and contextual analysis of relevant human security issues to policy makers, area specialists, advocacy groups, and the media. It is headquartered in Pretoria, South Africa with offices in Cape Town, South Africa, Nairobi, Kenya, Addis Ababa, Ethiopia and Dakar, Senegal.


Dr. Yaw Adu-Agyei Gyamfi is an inspired entrepreneur and committed proponent of African manufacturing. He is currently the CEO of the Danpong Group of Companies and Danadams Pharmaceuticals Industry Ltd. He has been a National Council Member of Ghana's Pharmaceutical Manufacturers Association for three years, and among other roles also holds the post of Board Chairman for the Ghana Cylinder Manufacturing Company, and is Commissioner for Ghana's Public Utilities Regulatory Commission. He is an Executive Council Member of the Ghana Employers Association, and an Examiner for the Ghana Pharmacy Council Professional Examination. He has BSc. in Chemistry and Mathematics from Clark College in Atlanta, Georgia, USA. He also holds a doctorate degree in Pharmacy from Mercer University in Atlanta Georgia, USA, and an Executive MBA from the Ghana Institute of Management and Public Administration (GIMPA), Accra, Ghana.






© 2011. Danadams